165 related articles for article (PubMed ID: 36977292)
1. Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance).
Boughey JC; Rosenkranz KM; Ballman KV; McCall L; Haffty BG; Cuttino LW; Kubicky CD; Le-Petross HT; Giuliano AE; Van Zee KJ; Hunt KK; Hahn OM; Carey LA; Partridge AH
J Clin Oncol; 2023 Jun; 41(17):3184-3193. PubMed ID: 36977292
[TBL] [Abstract][Full Text] [Related]
2. The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
Rosenkranz KM; Ballman K; McCall L; Kubicky C; Cuttino L; Le-Petross H; Hunt KK; Giuliano A; Van Zee KJ; Haffty B; Boughey JC
Ann Surg Oncol; 2018 Oct; 25(10):2858-2866. PubMed ID: 29987605
[TBL] [Abstract][Full Text] [Related]
3. Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study.
Di Lena É; Wong SM; Iny E; Mashal S; Basik M; Boileau JF; Martel K; Bassel MA; Meterissian S; Prakash I
Eur J Surg Oncol; 2024 Jun; 50(6):108266. PubMed ID: 38492259
[TBL] [Abstract][Full Text] [Related]
4. Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study.
Rosenkranz KM; Ballman K; McCall L; McCarthy C; Kubicky CD; Cuttino L; Hunt KK; Giuliano A; Van Zee KJ; Haffty B; Boughey JC
Ann Surg Oncol; 2020 Nov; 27(12):4650-4661. PubMed ID: 32699926
[TBL] [Abstract][Full Text] [Related]
5. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
Arthur DW; Winter KA; Kuerer HM; Haffty B; Cuttino L; Todor DA; Anne PR; Anderson P; Woodward WA; McCormick B; Cheston S; Sahijdak WM; Canaday D; Brown DR; Currey A; Fisher CM; Jagsi R; Moughan J; White JR
JAMA Oncol; 2020 Jan; 6(1):75-82. PubMed ID: 31750868
[TBL] [Abstract][Full Text] [Related]
7. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
Arvold ND; Taghian AG; Niemierko A; Abi Raad RF; Sreedhara M; Nguyen PL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2011 Oct; 29(29):3885-91. PubMed ID: 21900114
[TBL] [Abstract][Full Text] [Related]
8. The Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
Cuttino LW; McCall L; Kubicky C; Ballman KV; Le-Petross H; Hunt KK; Haffty B; Rosenkranz KM; Boughey JC
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):636-642. PubMed ID: 34634438
[TBL] [Abstract][Full Text] [Related]
9. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.
Pleijhuis RG; Kwast AB; Jansen L; de Vries J; Lanting R; Bart J; Wiggers T; van Dam GM; Siesling S
Breast; 2013 Oct; 22(5):773-9. PubMed ID: 23462681
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence of breast cancer: Salvage lumpectomy as an option for local treatment.
Sellam Y; Shahadi ID; Gelernter I; Zippel D; Sklair-Levy M; Symon Z; Galper S; Ben-David MA
Breast J; 2019 Jul; 25(4):619-624. PubMed ID: 31087430
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
[TBL] [Abstract][Full Text] [Related]
13. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.
Valachis A; Mamounas EP; Mittendorf EA; Hayashi N; Ishitobi M; Natoli C; Fitzal F; Rubio IT; Tiezzi DG; Shin HC; Anderson SJ; Hunt KK; Matsuda N; Ohsumi S; Totomi A; Nilsson C
Cancer; 2018 Jul; 124(14):2923-2930. PubMed ID: 29723396
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
[TBL] [Abstract][Full Text] [Related]
16. [Safety of breast-conserving treatment for triple-negative breast cancer].
Wang L; Ouyang T; Wang T; Xie Y; Fan Z; Fan T; Li J
Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):947-52. PubMed ID: 26850668
[TBL] [Abstract][Full Text] [Related]
17. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
Laurberg T; Lyngholm CD; Christiansen P; Alsner J; Overgaard J
Radiother Oncol; 2016 Jul; 120(1):98-106. PubMed ID: 27289261
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
20. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
Kunkler IH; Williams LJ; Jack WJ; Cameron DA; Dixon JM;
Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
